Rovati Bianca, Mariucci S, Manzoni M, Bencardino K, Danova M
Medical Oncology IRCCS Foundation S. Matteo University Hospital 27100 Pavia, Italy.
Eur J Histochem. 2008 Jan-Mar;52(1):45-52. doi: 10.4081/1185.
Dendritic cells (DCs) are the key antigen-presenting cells controlling the initiation of the T cell- dependent immune response. Currently, two peripheral blood DC subsets have been identified on the basis of their CD11c expression. The CD11c-negative (CD11c-) DCs (expressing high levels of CD123) are designated as lymphoid-derived DCs (DC2), whereas the CD11c+/CD123- cells, do identify the myeloid-derived DCs (DC1). A growing number of studies have been conducted in recent years on both the quantitative and functional alterations of DCs and their subsets in different pathological conditions. In the present study we assessed, using two different flow cytometric (FCM) techniques, the normal profile of blood DCs in 50 italian adult healthy subjects (M/F: 25/25, median age 42.5 years, range 20-65). The percentage and the absolute number of DCs and their subsets, were obtained starting from whole blood samples in two ways: 1) by calculating the number of DCs when gated as lineage-negative/ HLA-DR+ and identifing the two subsets as CD11c+ (DC1) and CD123+ (DC2) and 2) by using three specific markers: BDCA.1 (CD11c+ high/CD123+ low, myeloid DCs); BDCA.2 (CD11c-/ CD123+high, lymphoid DCs); BDCA.3 (CD11c+low /CD123-, myeloid DCs). Six parameters, 4-color FCM analysis were perfomed with a BD FACSCanto equipment. The mean values of the percentage and of the absolute number were: 0.5+/-0.2% and 30+/-11 cells/microL for DCs; 0.2+/-0.1% and 15+/-6 cells/microL for DC1; 0.2+/-0.1% and 15+/-7 cells/microL for DC2. The same values were: 0.2+/-0.1% and 16+/-7 cells/microL for BDCA.1; 0.2+/-0.1% and 12+/-7 cells/microL for BDCA.2; 0.02+/-0.01% and 2+/-1 cells/microL for BDCA.3, respectively. Our study confirmes that the two types of FCM analysis are able to identify the DC population. We also provides the first reference values on normal rates and counts of blood DCs in italian adult healthy subjects.
树突状细胞(DCs)是控制T细胞依赖性免疫反应启动的关键抗原呈递细胞。目前,已根据其CD11c表达鉴定出两种外周血DC亚群。CD11c阴性(CD11c-)DCs(高表达CD123)被指定为淋巴样来源的DCs(DC2),而CD11c+/CD123-细胞则可鉴定为髓样来源的DCs(DC1)。近年来,针对不同病理条件下DCs及其亚群的数量和功能改变开展了越来越多的研究。在本研究中,我们使用两种不同的流式细胞术(FCM)技术评估了50名意大利成年健康受试者(男/女:25/25,中位年龄42.5岁,范围20 - 65岁)血液DCs的正常情况。DCs及其亚群的百分比和绝对数量通过两种方式从全血样本中获取:1)通过计算门控为谱系阴性/HLA-DR+时的DCs数量,并将两个亚群鉴定为CD11c+(DC1)和CD123+(DC2);2)使用三种特异性标志物:BDCA.1(CD11c+高/CD123+低,髓样DCs);BDCA.2(CD11c-/CD123+高,淋巴样DCs);BDCA.3(CD11c+低/CD123-,髓样DCs)。使用BD FACSCanto设备进行了六参数四色FCM分析。百分比和绝对数量的平均值分别为:DCs为0.5±0.2%和30±11个细胞/微升;DC1为0.2±0.1%和15±6个细胞/微升;DC2为0.2±0.1%和15±7个细胞/微升。BDCA.1的相同值分别为0.2±0.1%和16±7个细胞/微升;BDCA.2为0.2±0.1%和12±7个细胞/微升;BDCA.3为0.02±0.01%和2±1个细胞/微升。我们的研究证实这两种FCM分析方法能够识别DC群体。我们还提供了意大利成年健康受试者血液DCs正常比例和计数的首个参考值。